These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23130343)

  • 1. Sensitization to multiple rh antigens by transfusion of random donor platelet concentrates in a -D- phenotype patient.
    Yun JW; Kang ES; Ki CS; Koh KC; Kim DW
    Ann Lab Med; 2012 Nov; 32(6):429-32. PubMed ID: 23130343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-D Rh antibodies appearing after apheresis platelet transfusion: stimulation by red cells or microparticles?
    Kitazawa J; Nollet K; Morioka H; Tanaka K; Inomata M; Kubuki Y; Ohto H
    Vox Sang; 2011 May; 100(4):395-400. PubMed ID: 21029111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alloimmunization to a high frequency Rh antigen].
    Cotorruelo C; Biondi C; Borras SG; Racca L; Brunetti D; Di Monaco R; Racca A
    Medicina (B Aires); 2006; 66(1):46-8. PubMed ID: 16555729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D+ platelet transfusions in D- patients: cause for concern?
    Bartley AN; Carpenter JB; Berg MP
    Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serologic study of red cells and sera from 18 Rh:32,-46 (RN/RN) persons.
    Le Pennec PY; Rouger P; Klein MT; Kornprobst M; Brossard Y; Boizard B; Salmon C
    Transfusion; 1989; 29(9):798-802. PubMed ID: 2511647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
    Hindawi S; Badawi M; Elfayoumi R; Elgemmezi T; Al Hassani A; Raml M; Alamoudi S; Gholam K
    Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Partial deletion of the D antigen in a family group. Determination of its antigenic density by flow cytometry].
    Hernández T; León G; Sánchez P
    Sangre (Barc); 1994 Apr; 39(2):139-43. PubMed ID: 7520193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-RH1 (anti-D) alloimmunization after transfusion of platelet concentrates from RH :1 donors].
    Duboeuf S; Flourié F; Courbil R; Oriol P; Benamara A; Chartier M; Rigal E; Garraud O
    Ann Biol Clin (Paris); 2009; 67(3):353-7. PubMed ID: 19411240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D--phenotype due to RHD-RHCE hybrid transcript in a case of severe haemolytic disease of newborn with anti-Rh 17(Hrₒ) antibodies.
    Mani A; Mishra G; Kulkarni S; Gupta D
    Transfus Med; 2021 Oct; 31(5):383-386. PubMed ID: 34121248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
    Moncharmont P
    Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories.
    Osby M; Shulman IA
    Arch Pathol Lab Med; 2005 Feb; 129(2):190-3. PubMed ID: 15679419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Hemolytic Transfusion Reaction Due to the "Anti-E" Rhesus Antibody in a Patient with Crohn's Disease.
    Ahn A; Hwang SH
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program.
    Vege S; Westhoff CM
    Immunohematology; 2006; 22(3):143-7. PubMed ID: 17105364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful transfusion care for a patient with the Rhesus -D- phenotype and antibodies against Rh17 and two additional alloantibodies.
    De Vooght KM; Demir AY; Folman CC; Schutgens RE; van Solinge WW; Kemperman H
    Ann Hematol; 2012 Jun; 91(6):963-4. PubMed ID: 21976107
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody.
    Mehr N; Fuja C; Simon C; Carll T; Alkhateb R; Wu S; Patel AA; Aldarweesh F
    Transfusion; 2024 Jun; 64(6):1161-1166. PubMed ID: 38682958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of alloimmunization to c (Rh4) in R1R1 patients who present with anti-E.
    Shirey RS; Edwards RE; Ness PM
    Transfusion; 1994 Sep; 34(9):756-8. PubMed ID: 8091462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet transfusion and immunization anti-Rh1: implication for immunoprophylaxis].
    Chambost H
    Transfus Clin Biol; 2014 Nov; 21(4-5):210-5. PubMed ID: 25282489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.